Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Feanix Biotechnologies
AddedMar 17, 2024
UpdatedJul 2, 2026
Feanix Biotechnologies

Feanix Biotechnologies

Seed

Revolutionizing animal breeding with DNA and software.

Founded
2022
Accelerator
Y Combinator logoY CombinatorS23
Overview
Compare
Fundraising
Employees
Website

Feanix Biotechnologies, founded to revolutionize the animal breeding industry, focuses on leveraging proprietary genetic testing and advanced software solutions. Their core mission is to simplify and enhance farm genetics, making breeding more efficient and effective. Feanix offers genetics and breeding as a service, targeting the trillion-dollar animal breeding market with innovative DNA-based technologies.

Notable figures affiliated with Feanix include experts in genetics and biotechnology, though specific names are not provided. The company has achieved significant milestones in genetic testing advancements, positioning itself as a leader in the industry. Feanix's impact is marked by its ability to streamline breeding processes, ultimately contributing to more sustainable and productive farming practices.

Feanix Biotechnologies - Similar Companies

BreedIT logo

BreedIT

Nest Genomics logo

Nest Genomics

nestgenomics.com

Myfloradna logo

Myfloradna

myfloradna.com

YieldX Solutions logo

YieldX Solutions

yieldx.biz

TL Biolabs logo

TL Biolabs

Genomelink logo

Genomelink

genomelink.io

Station X logo

Station X

Felix Biotechnology logo

Felix Biotechnology

20n logo

20n

dna37.com logo

dna37.com

GenomeNext logo

GenomeNext

Peregrine Biotechnology logo

Peregrine Biotechnology

Rev Genomics logo

Rev Genomics

revgenomics.com

Ohalo Genetics logo

Ohalo Genetics

ohalo.com

Future Fields logo

Future Fields

futurefields.io

Feanix Biotechnologies - Quick Facts

Who are Feanix Biotechnologies' competitors?

Companies similar to Feanix Biotechnologies include BreedIT, Nest Genomics, Myfloradna and YieldX Solutions.

When was Feanix Biotechnologies founded?

Feanix Biotechnologies was founded in 2022.

When was Feanix Biotechnologies' last funding round?

Feanix Biotechnologies' most recent funding round was for $500k (USD) in June 2023.

How much has Feanix Biotechnologies raised to-date?

As of Jun 1, 2023, Feanix Biotechnologies has raised a total of $500k (USD).

How many employees does Feanix Biotechnologies have?

Feanix Biotechnologies has 5 employees as of Sep 15, 2023.

Feanix Biotechnologies - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • AgTech
  • SaaS
  • Small Business